Chemomab Therapeutics (CMMB) Tops Q2 EPS by 9c
Get Alerts CMMB Hot Sheet
Join SI Premium – FREE
Chemomab Therapeutics (NASDAQ: CMMB) reported Q2 EPS of ($0.01), $0.09 better than the analyst estimate of ($0.10).
For earnings history and earnings-related data on Chemomab Therapeutics (CMMB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla readies August launch of CyberCab - The Information
- XP Inc. (XP) Tops Q2 EPS by 8c
- NNN REIT adds two directors amid board succession planning
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share